Trial Profile
The early Phase 2 clinical study of JTS-653 in Post-Herpetic Neuralgia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs JTS 653 (Primary)
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Japan Tobacco
- 01 Jun 2016 New trial record